Aldurazyme е определен като „ лекарство сирак “ (лекарство, използвано при редки заболявания).
Because the number of patients with MPS I is low, the disease is considered ‘ rare’, and Aldurazyme was designated an ‘ orphan medicine ’ (a medicine used in rare diseases) on 14 February 2001.